Spinecap SAS’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.2M Buy
25,016
+1,350
+6% +$635K 3.33% 10
2026
Q1
$9.38M Sell
23,666
-491
-2% -$222K 3.44% 14
2025
Q4
$11.3M Buy
+24,157
New +$10.7M 4.88% 10

Other funds holding SNPS

Spinecap SAS's SNPS Position: Q2 2026 in Review

Spinecap SAS increased its Synopsys (SNPS) stake by 5.7% in Q2 2026, buying an estimated $635K and bringing the position to 25,016 shares worth $11.2M. The position accounts for 3.33% of the portfolio, ranked #10.

Spinecap SAS first reported a position in SNPS in Q4 2025 and has held it in 3 quarters since. The position peaked at $11.3M in Q4 2025. 489 funds tracked by Wall St. Rank hold SNPS as of Q2 2026.

  • Spinecap SAS held 25,016 shares of Synopsys worth $11.2M as of Q2 2026.
  • Spinecap SAS bought 1,350 Synopsys shares in Q2 2026, an estimated $635K.
  • Synopsys made up 3.33% of Spinecap SAS's portfolio in Q2 2026, its #10 holding.
  • Spinecap SAS first reported a position in Synopsys in Q4 2025 and has held it in 3 quarters since.
  • Spinecap SAS's Synopsys position peaked at $11.3M in Q4 2025.
  • 489 funds tracked by Wall St. Rank held Synopsys as of Q2 2026.

Based on Spinecap SAS's 13F filing for Q2 2026, filed 27 Jul 2026.